Read article—Anne Hoen, a professor of epidemiology, is featured in coverage of a Dartmouth study finding that some patients with type O blood and alpha-gal antibodies can have severe allergic reactions to certain plasma or platelet transfusions. “Even if it’s an abundance of caution, it could save the patient’s life,” Hoen said.

Read article—Features research led by James Sargent, a professor of community and family medicine, finding that greater exposure to alcohol marketing is associated with increased drinking-related outcomes among children and adolescents. The authors call for better measures of cumulative marketing exposure, particularly across digital and social media.

Read article—Nancy Dunbar and Richard Kaufman, professors of pathology and laboratory medicine, co-led a study finding that alpha-gal syndrome can trigger severe allergic reactions in some blood transfusion recipients. “We anticipate that this will change transfusion practices in the U.S., at least in AGS high-prevalence regions,” Kaufman said. (Similar coverage in Medical Daily.)

Read article—Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, discusses state laws restricting AI therapy tools in the context of his work developing Therabot, a generative AI mental health chatbot. Jacobson said the laws “don’t often have exemptions for these clinical products that are effective and safe.”

Read article—Features Michael Heinz, an assistant professor of psychiatry, and Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, discussing their development of Therabot, a generative AI mental health chatbot that has shown clinical results in a published trial. “Digital technologies are one of the ways that folks have tried to enable better access to healthcare,” Jacobson said. (Picked up by Yahoo.)

Read article—Features a study led by Lynn Fiellin, a professor of biomedical data science and medicine, and postdoctoral research fellow Caroline Barry showing that PlaySmart, a digital behavioral health game developed in the Fiellin lab, reduced depression symptoms among teens and improved attitudes toward seeking mental health care. “Even small improvements could have meaningful public health impact if a serious game like this could be delivered at scale,” Fiellin said.

Read article—Paul Holtzheimer, a professor of psychiatry, is featured as an expert on renewed efforts to test deep brain stimulation for treatment-resistant depression after an earlier trial missed its primary endpoint. “The treatment didn’t fail. The study failed,” Holtzheimer said.

Read article—Features a study led by Lynn Fiellin, a professor of biomedical data science and medicine, and postdoctoral research fellow Caroline Barry showing that PlaySmart, a digital behavioral health game developed in the Fiellin lab, reduced depression symptoms among teens and improved attitudes toward seeking mental health care. “Serious games for prevention and mental health promotion are a rapidly growing area, but the evidence base is still emerging, ” Fiellin said. (Similar coverage in Talker.news, SWNS, and Fresno Bee.)

Read article—Features research co-led by Caroline Barry, a postdoctoral research fellow in the Center for Technology and Behavioral Health, finding that a digital behavioral health game produced a sustained reduction in depressive symptoms among adolescents over 12 months. “Because behavioral health games like PlaySmart are digital and self-guided, they have tremendous potential to reach adolescents across a wide range of settings who might not otherwise receive care,” Barry said.

Read article—Megan Romano, an associate professor of epidemiology, comments on confirmed PFAS contamination at Lebanon Municipal Airport. “While it’s always a shock to find any amount of PFAS in our own backyard, PFAS contamination at airports is quite common,” Romano said.